Yağcı, Tarık
Çınar, Ramazan
Altıner, Halil İbrahim
Dündar, Rıza
Yıldızhan, Kenan
Article History
Received: 16 September 2024
Revised: 10 October 2024
Accepted: 10 October 2024
First Online: 22 January 2025
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
: This work does not contain any studies involving human and animal subjects.
: The authors of this work declare that they have no conflicts of interest.
: In this study, where the role of the TRPM2 channel in DOX-induced cell damage in the Hep-2 cell line was investigated as a first, the limitations of the study were not using dose ranges or different antagonists for TRPM2 channel in Hep-2 cells due to limited budget and also not supporting different molecular techniques.